Jeff Johnson

Stock Analyst at Baird

(4.65)
# 201
Out of 5,044 analysts
148
Total ratings
58.42%
Success rate
29.07%
Average return

Stocks Rated by Jeff Johnson

DexCom
Sep 26, 2025
Maintains: Outperform
Price Target: $112$90
Current: $68.18
Upside: +32.00%
The Cooper Companies
Aug 28, 2025
Maintains: Outperform
Price Target: $97$85
Current: $69.58
Upside: +22.16%
Alcon
Aug 21, 2025
Maintains: Outperform
Price Target: $108$95
Current: $73.60
Upside: +29.08%
Beta Bionics
Jul 30, 2025
Maintains: Neutral
Price Target: $15$17
Current: $26.79
Upside: -36.54%
Henry Schein
Jul 14, 2025
Downgrades: Neutral
Price Target: $82$72
Current: $62.32
Upside: +15.53%
Envista Holdings
May 27, 2025
Upgrades: Outperform
Price Target: $21$23
Current: $19.98
Upside: +15.12%
Zimmer Biomet Holdings
May 6, 2025
Maintains: Outperform
Price Target: $130$115
Current: $99.71
Upside: +15.33%
Tandem Diabetes Care
May 1, 2025
Maintains: Neutral
Price Target: $33$24
Current: $15.15
Upside: +58.42%
Stryker
Oct 30, 2024
Maintains: Outperform
Price Target: $378$405
Current: $369.59
Upside: +9.58%
Align Technology
Oct 24, 2024
Maintains: Outperform
Price Target: $325$276
Current: $131.91
Upside: +109.23%
Upgrades: Outperform
Price Target: $180$238
Current: $316.17
Upside: -24.72%
Maintains: Outperform
Price Target: $67$70
Current: $31.99
Upside: +118.82%
Maintains: Outperform
Price Target: $53$61
Current: $14.92
Upside: +308.85%
Maintains: Outperform
Price Target: $78$67
Current: $12.86
Upside: +421.00%